@article{ATM20202,
author = {Mark Löwenberg},
title = {Is there a beneficial effect of adding azathioprine to adalimumab in Crohn’s disease patients?},
journal = {Annals of Translational Medicine},
volume = {6},
number = {13},
year = {2018},
keywords = {},
abstract = {Crohn’s disease (CD) is a debilitating chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract. The disease is characterized by transmural inflammation and typically has a relapsing course over time. Up to now, there is no curative treatment.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/20202}
}